Matches in DBpedia 2014 for { ?s ?p Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. It was established in 1995 as a spin out from Oxford University. The lead product is TroVax, a therapeutic cancer vaccine for multiple solid cancers, which is in Phase III development incollaboration with Sanofi-Aventis.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Oxford_BioMedica comment "Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. It was established in 1995 as a spin out from Oxford University. The lead product is TroVax, a therapeutic cancer vaccine for multiple solid cancers, which is in Phase III development incollaboration with Sanofi-Aventis.".